Amedica Files for IPO (press release)
Amedica Corporation, a Salt Lake City, Utah-based silicon nitride orthopedic and spine implant company, has filed with the U.S. Securities and Exchange Commission to raise up to $35 million in an initial public offering (IPO). The company, which was founded in 1996 and booked $23 million in sales for the 12 months ended June 30, 2013, plans to list on the NASDAQ under the symbol AMDA.
Amedica initially filed confidentially on September 23, 2013. The company had previously filed for an IPO in May 2007 before withdrawing three months later. JMP Securities is the only listed bookrunner on the deal. No pricing terms were disclosed.
Earlier this year, Amedica released the Valeo II AL interbody fusion device in the United States; and signed a distribution agreement with K2M to get its silicon nitride-based implants into the European market.